Furthermore, our results showed that IBC patients are characterized by a high frequency of the Treg (Foxp3+CD4+) subset representing 23% of total CD4+ T cells drained from the tumor microenvironment. The gene discussed is FOXP3; the disease is inflammatory breast carcinoma.